Fully licensed, export-ready Colombian cultivation and processing platform with GACP certification, EU-GMP Part I approval, and established EU distribution access. Proven export execution with ~1 tonne already shipped into European medical markets; includes advanced processing infrastructure and PLC 2500 purification system.
Unbeatable Production Arbitrage
Ultra-Low Costs
All-in production costs of €0.30 per gram, with further downward pressure expected as the facility scales toward its 25+ tonne licensed capacity.
Elite Genetics
Proven high-THC cultivars (mid-20% THC) featuring advanced terpene profiles tailored for European and Australian markets.
Ideal Climate
Located in a premium microclimate with stable, predictable conditions enabling year-round cultivation.
Institutional-Grade Infrastructure & Scalability
Immediate Capacity
1.7 hectares of interconnected greenhouses currently producing 5.7 tonnes of dried flower annually.
Expansion Ready
Fully licensed 15-hectare site with capacity for 25+ tonnes, enabling significant scale-up with minimal additional capex.
Operational Autonomy
Dedicated on-site power substation with diesel backup and a 20,000 m³ rainwater reservoir supported by a sophisticated water treatment system.
Advanced Post-Harvest & Processing Technology
Dual-Track Facility
Separate buildings for GACP post-harvest and EU-GMP / TGA GMP-compliant processing.
Unique Technology Edge
Includes Colombia’s only PLC 2500 purification system and an X-ray sterilization unit required for the Australian market.
On-Site Laboratory
Fully equipped lab enabling real-time potency and purity testing to ensure pharmaceutical-grade standards.
Validated Global Export Track Record
Proven Market Access
One of the few Colombian producers with established exports; approximately 1 tonne already delivered to European markets.
De-Risked Revenue
Sale includes a binding 3-year offtake agreement and established distribution relationships in Germany and the UK.
Turnkey Transition & Strategic Value
01
Investment ValueOver USD $12M already invested in infrastructure, licensing, and elite genetics.
02
Financial StatusDebt-free; all related-party debt is forgiven at closing.
03
Shortcut to MarketBypasses the typical 3-year development cycle including site selection, construction, and regulatory approvals in Colombia.
04
Management ContinuityCore leadership team, including production specialists, will remain to ensure a seamless operational transition.
05
Tax EfficiencyTax loss carryforwards (~USD $1.5M) available through 2036, preserved under the share sale structure.
Financial Forecast
Parameter / Metric
Conservative Scenario
Base Scenario
Optimistic Scenario
Asking / Target Price
TBD (On Request)
TBD (On Request)
TBD (On Request)
Annual Finished Extraction Capacity
~5,000 kg
~8,000 kg
~12,000 kg
Average Export Price / Gram (EU GMP)
$2.50 / g
$3.50 / g
$4.50 / g
Estimated Gross Revenue
~$12,500,000 USD
~$28,000,000 USD
~$54,000,000 USD
Estimated Production & OPEX
~$6,500,000 USD
~$12,000,000 USD
~$21,000,000 USD
Estimated EBITDA
~$6,000,000 USD
~$16,000,000 USD
~$33,000,000 USD
EBITDA Margin
~48%
~57%
~61%
Basic Details
Published on May 21, 2026 Updated on November 03, 2026